OVERVIEW OF RANDOMIZED CONTROLLED TRIALS

Randomized controlled trials are considered to be the gold standard in clinical studies to establish level of evidence in medical research. But, they are not easy to conduct and various other aspects have to be looked into. Randomization offers each enrolled subject equal chance of being allocated to the intervention and the control groups. Randomized control trial (RCT) is most powerful tool in clinical research. In this, subjects  are assigned to different groups of interventions by chance for comparison. RCT is only study design which can help us evaluate a new treatment.  By assigning participants to different intervention groups by chance, comparison between the interventions groups is made. Purpose of randomization is to make the treatment groups comparable, eliminates the source of and it ensures that the difference in groups is only due to trial treatments. In this article, we review randomized control trial with special emphasis on various types of randomized controlled trials, their characteristics, the process of randomization, and advantages and drawbacks of randomized controlled trials. Key words: Randmized controlled trials, study design, randomization, clinical research

[1]  William H. Barker,et al.  CLINICAL EPIDEMIOLOGY: THE ESSENTIALS. , 1984 .

[2]  M. Daniels.  Streptomycin treatment of pulmonary tuberculosis. , 1949, Medical times.

[3]  S. Duffy,et al.  Interpretation of the breast screening trials: a commentary on the recent paper by Gøtzsche and Olsen. , 2001, Breast.

[4]  C B Begg,et al.  Treatment allocation methods in clinical trials: a review. , 1985, Statistics in medicine.

[5]  D. Moher,et al.  CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials , 2010, Journal of clinical epidemiology.

[6]  M. Graffar.  [Modern epidemiology]. , 1971, Bruxelles medical.

[7]  K. Woods.  Mega-trials and management of acute myocardial infarction , 1995, The Lancet.

[8]  F J Ingelfinger,et al.  International Journal of Epidemiology , 1973, The New England journal of medicine.

[9]  Douglas G Altman,et al.  Treatment allocation in controlled trials: why randomise? , 1999, BMJ.

[10]  Sander Greenland,et al.  Modern Epidemiology 3rd edition , 1986 .

[11]  J A Smyth,et al.  Determining optimal therapy--randomized trials in individual patients. , 1986, The New England journal of medicine.

[12]  Christopher J Weir,et al.  Comparison of stratification and adaptive methods for treatment allocation in an acute stroke clinical trial. , 2004, Statistics in medicine.

[13]  Amanda J. Lee,et al.  Medical uses of statistics, 2nd ed , 2001 .

[14]  Gopinath Ranjith,et al.  Interferon-α-Induced Depression: When a Randomized Trial Is Not a Randomized Controlled Trial , 2005, Psychotherapy and Psychosomatics.

[15]  Anupam Prakash,et al.  Scientific study designs for research: an overview , 2012 .

[16]  D. Sackett,et al.  Controversy in counting and attributing events in clinical trials. , 1979, The New England journal of medicine.

[17]  James Frane,et al.  A Method of Biased Coin Randomization, Its Implementation, and Its Validation , 1998 .

[18]  Douglas G Altman,et al.  Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study , 2008, BMJ : British Medical Journal.

[19]  K. Lui,et al.  Randomized consent designs for clinical trials: an update by M. Zelen, Statistics in Medicine 1990; 9: 645–656 , 2002, Statistics in medicine.

[20]  Sally Hopewell,et al.  The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed , 2010, BMJ : British Medical Journal.

[21]  G. Norman,et al.  Randomized controlled trials. , 2004, AJR. American journal of roentgenology.

[22]  Allan Donner,et al.  Design and Analysis of Cluster Randomization Trials in Health Research , 2001 .

[23]  John Hoey,et al.  Clinical trial registration: a statement from the International Committee of Medical Journal Editors. , 2005, Circulation.

[24]  M. Meldrum,et al.  A brief history of the randomized controlled trial. From oranges and lemons to the gold standard. , 2000, Hematology/oncology clinics of North America.

[25]  N. D’Esopo,et al.  STREPTOMYCIN TREATMENT OF PULMONARY TUBERCULOSIS , 1998, The Journal of clinical investigation.

[26]  B. Brenner,et al.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. , 2001, The New England journal of medicine.

[27]  J C Bailar,et al.  Crossover and self-controlled designs in clinical research. , 1984, The New England journal of medicine.

[28]  N. Black.  CONSORT , 1996, The Lancet.

[29]  S. Bhalerao,et al.  Study designs , 2010, International journal of Ayurveda research.

[30]  D. Moher,et al.  CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials , 2010, Journal of pharmacology & pharmacotherapeutics.